Vanderbilt-Ingram Cancer Center

What Vanderbilt-Ingram Cancer Center does

Vanderbilt-Ingram Cancer Center (VICC) is an NCI-designated Comprehensive Cancer Center and a department within Vanderbilt University Medical Center (VUMC), headquartered in Nashville, Tennessee. It is one of only 57 institutions nationally to hold the NCI "Comprehensive" designation — the highest federal recognition for integrated cancer research and patient care — and is a member of the National Comprehensive Cancer Network and the NCI National Clinical Trials Network. VICC operates eight structured research programs (Breast Cancer, Cancer Epidemiology, Cancer Health Outcomes & Control, Gastrointestinal Cancer, Genome Maintenance, Host-Tumor Interactions, Signal Transduction and Chemical Biology, and Translational Research and Interventional Oncology), two Specialized Programs of Research Excellence (SPOREs) in breast and gastrointestinal cancer, a clinical trials program, hereditary cancer and health disparities research initiatives, and a Comprehensive Radiopharmaceutical Therapy Center of Excellence.

VICC's clinical footprint comprises the main Nashville campus plus a satellite clinic opened in December 2025 in Wilson County (Lebanon, TN), supported by digital channels including the MyHealth at Vanderbilt patient portal, the vicc.org site, and patient-facing content such as the BBC StoryWorks/UICC "Rewriting Cancer" documentary series. Revenue mechanics combine patient care billing through VUMC's clinical service line, federal and NCI grant funding unlocked by Comprehensive designation and SPORE awards, donor-supported research through give.vanderbilthealth.org, and ancillary activity from multicenter clinical research collaborations (e.g., the PREDICT-DNA study with Personalis across 24 US cancer centers). Customer segments center on cancer patients and their caregivers, with secondary stakeholders including community advocates, volunteers, donors, and referring physicians; Go-to-market is community-led and trust-driven rather than transactional, leveraging clinical reputation, physician referrals, and philanthropy.

Critically, VICC is a non-profit academic medical center rather than an investable operating company: it has no independent equity, no venture funding history, and its commercial and financial metrics are not separately reported. The entity listed here should be understood as the institutional unit for any PE/VC/M&A audience evaluating exposure to academic oncology delivery, NCI-funded research, or partnership with VUMC — not as a standalone investment target.

Name

Vanderbilt-Ingram Cancer Center

Legal name

Vanderbilt-Ingram Cancer Center

Website

https://vicc.org

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Short description

Vanderbilt-Ingram Cancer Center is an NCI-designated Comprehensive Cancer Center within Vanderbilt University Medical Center that delivers integrated cancer research, clinical trials, and patient care in Nashville, Tennessee. It serves cancer patients and caregivers regionally, funded by clinical billing, federal research grants, and philanthropy.

Ownership category

akta.pro rank

Product category

Comprehensive Cancer Care

NAICS

General Medical and Surgical Hospitals (62211)

SIC

Services-Health Services (8000)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

Keywords

• Cancer treatment services
• Clinical trials research
• Translational oncology research
• Comprehensive cancer care
• Cancer prevention programs

Headquarters

HQ city

Nashville

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Patient Care Services: Clinical services providing cancer diagnosis, treatment, and management for patients through Vanderbilt University Medical Center.
2. Research Grants and Funding: NCI-designated Comprehensive Cancer Center status enables competitive research grant funding from National Cancer Institute and other federal agencies.
3. Philanthropy and Donations: Donor-supported research programs and major gifts supporting cancer research initiatives.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Vanderbilt-Ingram Cancer Center (VICC) is an NCI-designated Comprehensive Cancer Center providing integrated cancer research, clinical care, clinical trials, and education programs. Its core offerings span specialty cancer diagnostics and treatment for individual patients, access to NCI-sponsored clinical trials, specialized SPORE research programs in breast and gastrointestinal cancers, and a Radiopharmaceutical Therapy Center of Excellence. The center also delivers hereditary cancer, health disparities, and early detection research initiatives together with training programs for clinicians and researchers.

Product overview

Vanderbilt-Ingram Cancer Center is a single integrated cancer center operating as one of 57 National Cancer Institute-designated Comprehensive Cancer Centers. The center provides a unified portfolio of research programs (including Breast Cancer, GI Cancer, Genome Maintenance, Host-Tumor Interactions, Signal Transduction, Cancer Epidemiology, Health Outcomes & Control, and Translational Research), specialized SPORE programs in breast and GI cancer, clinical trial access, patient care services, education programs, and community outreach. The center offers a comprehensive range of cancer care from prevention and early detection through treatment and survivorship support.

Differentiator

Problem solved

Functional benefit

Brands

• SPORE in Breast Cancer: Specialized Programs of Research Excellence focusing on breast cancer
• SPORE in Gastrointestinal Cancer
• MyHealth at Vanderbilt

Products and services

• Patient Care Services Comprehensive cancer diagnosis, treatment, and management for cancer patients through Vanderbilt University Medical Center, including specialty treatments, doctor search, appointment scheduling, and support services.
• Clinical Trials Program Searchable clinical trial enrollment program providing cancer patients and referring physicians with access to NCI-sponsored oncology trials, including dedicated trial search tools for patients and physicians.
• Radiopharmaceutical Therapy Center of Excellence NCI-recognized center providing targeted radiopharmaceutical therapy using radioactive drugs to deliver radiation to cancer cells or tumor microenvironment for cancer patients.
• MyHealth at Vanderbilt Patient Portal Online self-serve patient portal providing patients with access to medical records, test results, and secure messaging with their doctor's office.
• Education, Training, and Career Development Programs Education, training, and career development programs for researchers and healthcare professionals in oncology, including the Annual Scientific Retreat and research training pathways.
• Wilson County Cancer Clinic Regional satellite cancer clinic offering local diagnosis, treatment, and follow-up cancer care services for patients in Wilson County and surrounding areas.

Quantifiable outcome

• VUMC named Comprehensive Radiopharmaceutical Therapy Center of Excellence (2024)

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Meharry-Vanderbilt-Tennessee State Cancer PartnershipcoreStrategic or Co-development PartnerCollaboration with Meharry Medical College and Tennessee State University focused on reducing cancer disparities and advancing cancer research in minority communities.
• BBC StoryWorks Commercial ProductionsminorGTM or Marketing PartnerPartnered to produce Rewriting Cancer digital series featuring patient stories for Union of International Cancer Control (UICC).
• Union of International Cancer Control (UICC)minorStrategic or Co-development PartnerGlobal cancer control organization; VICC content featured in UICC storytelling initiatives.
• Vanderbilt University Medical CentercoreOthersVICC is part of Vanderbilt University Medical Center, providing administrative and institutional support.
• Personalis, Inc.minorStrategic or Co-development PartnerVICC participated in the PREDICT-DNA study evaluating Personalis' NeXT Personal MRD test for neoadjuvant treatment monitoring in breast cancer across 24 US cancer centers.
• Shanghai Women's Health StudyminorStrategic or Co-development PartnerInternational epidemiological research partnership studying women's health outcomes.
• Southern Community Cohort StudyminorStrategic or Co-development PartnerResearch collaboration studying health disparities in minority communities.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Memorial Sloan Kettering Cancer Center: One of the original NCI-designated Comprehensive Cancer Centers with a similar integrated research-and-clinical-care model. Comparable scale in clinical trials, translational research, and specialty oncology programs — making it a benchmark peer for VICC.
• Abramson Cancer Center at the University of Pennsylvania: NCI Comprehensive Cancer Center with deep translational and radiopharmaceutical therapy capability. Comparable peer on novel modality therapy lines and investigator-initiated trial volume.
• Johns Hopkins Sidney Kimmel Comprehensive Cancer Center: NCI Comprehensive Cancer Center with similar SPORE and translational programs across multiple cancers. Comparable in research intensity, clinical trial access, and academic medical center integration.
• UCSF Helen Diller Family Comprehensive Cancer Center: NCI Comprehensive Cancer Center within an academic medical center with strong translational and epidemiology programs. Direct comparable on research-program breadth (genome maintenance, signal transduction, epidemiology).
• Winship Cancer Institute of Emory University: NCI-designated Comprehensive Cancer Center based in Atlanta — the closest Southeastern regional peer to VICC. Direct competition for patients and trials within VICC's core geography.
• Mayo Clinic Cancer Center: NCI Comprehensive Cancer Center embedded in a large academic medical system, similar in structure to VICC's relationship with VUMC. Comparable scale of clinical trials, multi-site operations, and specialty cancer programs.
• MD Anderson Cancer Center: Largest U.S. NCI-designated Comprehensive Cancer Center with deep SPORE-style translational programs and clinical trial volume across multiple cancers. Direct competitor for talent, grant dollars, and complex oncology referrals.
• Duke Cancer Institute: NCI-designated Comprehensive Cancer Center in the Carolinas with strong clinical trial and translational programs. Direct Southeastern regional competitor for catchment and trial sponsor attention.
• Fred Hutchinson Cancer Center: NCI-designated Comprehensive Cancer Center with leading translational and immunotherapy research programs. Comparable research-model peer, particularly for genomic and host-tumor interaction work.
• Dana-Farber Cancer Institute: Harvard-affiliated NCI Comprehensive Cancer Center with strong translational research and industry-sponsored trial activity. Closely comparable to VICC in integrating bench research with clinical care delivery.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/vanderbiltingram
• Instagraminstagram.com/vumc_cancer
• Xx.com/vumchealth
• LinkedInlinkedin.com/company/vanderbilt-ingram-cancer-ctr

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vanderbilt-Ingram Cancer Center